Histogenics' Series B - II Round

Histogenics raised a round of funding on January 06, 2014.

Histogenics is a regenerative medicine company that combines cell therapy and tissue engineering technologies to develop products for tissue repair and regeneration. Histogenics' flagship product…

Articles about Histogenics' Series B - II Round: